| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/10/1997 | CA2228257A1 Osmotic device for the continuous release of active substances into the fluids of the gastro-intestinal tract |
| 04/10/1997 | CA2207084A1 Controlled release matrix for pharmaceuticals |
| 04/09/1997 | EP0767178A1 Protein which induces interferon-gamma production by immunocompetent cell |
| 04/09/1997 | EP0766960A1 External preparations for treating dermatoses |
| 04/09/1997 | EP0766661A1 Polyolpolyhydroxystearates |
| 04/09/1997 | EP0766576A1 Renewable neural implant device |
| 04/09/1997 | EP0766570A1 Methods for treating respiratory disease |
| 04/09/1997 | EP0766564A1 Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
| 04/09/1997 | EP0766558A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
| 04/09/1997 | EP0766557A1 Topical compositions comprising n-acetyl-l-cysteine |
| 04/09/1997 | EP0766556A1 Volume-expandable flat article suitable for use as an active substance carrier, in particular for oral use |
| 04/09/1997 | EP0766555A1 Nanoparticles stabilized and filterable in sterile conditions |
| 04/09/1997 | EP0766554A1 Polymer microparticles for drug delivery |
| 04/09/1997 | EP0766553A1 Intraocular irrigating solution containing agent for controlling iop |
| 04/09/1997 | EP0766538A1 Subcutaneous implant |
| 04/09/1997 | EP0766514A1 Flash flow formed solloid delivery systems |
| 04/09/1997 | EP0693878B1 Iodine barrier teat dip |
| 04/09/1997 | EP0664696B1 Sustained release compositions for treating periodontal disease |
| 04/09/1997 | EP0597033B1 Igf-1 to improve the neural condition |
| 04/09/1997 | EP0588875B1 Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
| 04/09/1997 | EP0559813B1 Controlled release compositions |
| 04/09/1997 | EP0537292B1 Water insoluble derivatives of hyaluronic acid |
| 04/09/1997 | EP0436667B1 Biodegradable in-situ forming implants |
| 04/09/1997 | CN1147203A Molten granulated sucralfate preparation and process for producing same |
| 04/09/1997 | CN1147202A Wet granulation formulation for bisphosphonic acids |
| 04/09/1997 | CN1146914A Pill for treatment of anal fistula |
| 04/09/1997 | CN1146910A Chinese medicinal food |
| 04/09/1997 | CN1146909A Antidotal medical ointment |
| 04/09/1997 | CN1146908A Chinese medicine preparation for treatment of gastric ulcer, duodenal ulcer and gastritis |
| 04/09/1997 | CN1146907A Prescription and process of medicine for treatment of ophthalmopathia |
| 04/09/1997 | CN1146906A Prescription and process of exterior-use medicine for treatment of hemiparalysis and pain in waist and lower extremities |
| 04/09/1997 | CN1146905A Prescription and process of exterior-use medicine for treatment of furuncle of back |
| 04/09/1997 | CN1146904A Antibacterial herb medicine tablet |
| 04/09/1997 | CN1146900A Narcotic capsule and its preparing process |
| 04/09/1997 | CN1146894A Process for making dry granule of Chinese medicine extract tablet |
| 04/09/1997 | CN1146863A Method for producing sweetmeat for refreshing mouth |
| 04/08/1997 | US5618899 Crosslinked pressure-sensitive adhesives tolerant of alcohol-based excipients used in transdermal delivery devices and method of preparing same |
| 04/08/1997 | US5618850 Hydroxy-acid cosmetics |
| 04/08/1997 | US5618845 Acetamide derivative having defined particle size |
| 04/08/1997 | US5618840 Prevention growth of helicobacter |
| 04/08/1997 | US5618800 Thermally-gelling drug delivery vehicles containing cellulose ethers |
| 04/08/1997 | US5618799 Storage stability, noncaking, nonscattering, adhesion |
| 04/08/1997 | US5618786 Aerosolization of protein therapeutic agent |
| 04/08/1997 | US5618563 Encapsulating an anesthetic drug into biocompatiable microparticles |
| 04/08/1997 | US5618562 Spherical granule, production method thereof and medicinal preparation using said granule |
| 04/08/1997 | US5618561 Preparation of highly hydrated self-supporting hyaluronic acid containing films |
| 04/08/1997 | US5618560 Controlled release erodible composition |
| 04/08/1997 | US5618559 Method of making modified-release metronidazole compositions |
| 04/08/1997 | US5618557 Prophylactic treatment of allergic contact dermatitis |
| 04/08/1997 | US5618555 Percutaneous absorption preparation |
| 04/08/1997 | US5618553 Contacting localized region of eye with polymer implant having reversibly associated modulating agent which is released at rate such that target cells are primarily affected |
| 04/08/1997 | US5618552 Aliphatic; useful for surgical devices such as sutures |
| 04/08/1997 | US5618550 Method for treatment of abnormal conditions of the epithelium of bodily orifices |
| 04/08/1997 | US5618539 Aqueous solution comprising a heat resist stabilizer lysine or/and arginine |
| 04/08/1997 | US5618531 Method for increasing the viability of cells which are administered to the brain or spinal cord |
| 04/08/1997 | US5618527 Calcium polycarbophil sprinkle |
| 04/08/1997 | US5618523 Oleic acid derivatives; hair, skin lotions |
| 04/08/1997 | US5618516 Composition also containing water, thickener, emulsifier, propellant; applied as foam for maximum penetration |
| 04/08/1997 | US5618515 Aerosol spray composition for the treatment of dermal burns by cooling and anesthetizing the wound and valved container for dispensing same |
| 04/08/1997 | US5617877 Absorption by an acidic buffer gel to prevent from sexual disease, menstrual toxic shock infection and pregnancy |
| 04/08/1997 | CA2137164C A new composition containing selegiline |
| 04/08/1997 | CA2091360C Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| 04/03/1997 | WO1997012052A1 Transduction of hematopoietic cells by viral vector and a cationic lipid |
| 04/03/1997 | WO1997011935A1 Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes |
| 04/03/1997 | WO1997011739A1 Method and apparatus for oral spray administration of caffeine |
| 04/03/1997 | WO1997011711A1 Iron dextran formulations |
| 04/03/1997 | WO1997011709A1 Anthelmintic macrocyclic lactone compositions |
| 04/03/1997 | WO1997011699A1 1,2,4-benzotriazine oxides formulations |
| 04/03/1997 | WO1997011696A1 Transdermal administration of ropinirole and analogs thereof |
| 04/03/1997 | WO1997011689A1 Transdermal matrix system |
| 04/03/1997 | WO1997011688A1 Use of a vinyl acetate/n-vinyl-2-pyrrolidone copolymer in a transdermal matrix system |
| 04/03/1997 | WO1997011687A1 Transdermal matrix system |
| 04/03/1997 | WO1997011686A1 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
| 04/03/1997 | WO1997011685A1 Method for synthesizing microcapsules of predetermined permeability |
| 04/03/1997 | WO1997011684A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | WO1997011683A2 Stabilised phospholipid compositions |
| 04/03/1997 | WO1997011682A2 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 04/03/1997 | WO1997011681A1 Sustained release delivery system and long acting narcotic analgesics and antagonists |
| 04/03/1997 | WO1997011680A2 Hormone replacement therapy method and hormone dispenser |
| 04/03/1997 | WO1997011677A1 Cosmetic deodorant products containing a polymer/fragrance-encapsulated bicarbonate ingredient |
| 04/03/1997 | WO1997011672A1 Hair care perming agents and processes |
| 04/03/1997 | WO1997011655A1 Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| 04/03/1997 | WO1997011607A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | WO1997007786A3 Use of lipids as adjuvents in the production of solid medicinal forms by the melt extrusion process |
| 04/03/1997 | WO1997006787A3 Controlled release products |
| 04/03/1997 | DE19536504A1 Fluorierte Alkane und ihre Verwendung Fluorinated alkanes and their use |
| 04/03/1997 | DE19536394A1 Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze Solid dosage forms obtainable by extrusion of an isomalt-containing polymer-drug melt |
| 04/03/1997 | DE19536387A1 Verfahren zur Herstellung von vitaminhaltigen festen Zubereitungen A process for preparing vitamin-containing solid preparations |
| 04/03/1997 | CA2502761A1 Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| 04/03/1997 | CA2233343A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | CA2233334A1 Transdermal administration of ropinirole and analogs thereof |
| 04/03/1997 | CA2233280A1 Sustained release delivery system and long acting narcotic analgesics and antagonists |
| 04/03/1997 | CA2233171A1 Transdermal matrix system |
| 04/03/1997 | CA2233162A1 Transdermal matrix system |
| 04/03/1997 | CA2233135A1 Stabilised phospholipid compositions |
| 04/03/1997 | CA2232870A1 Method for synthesizing microcapsules of predetermined permeability |
| 04/03/1997 | CA2232815A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | CA2232621A1 Hormone replacement therapy method and hormone dispenser |
| 04/03/1997 | CA2230940A1 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 04/02/1997 | EP0765843A1 Deactivating or destroying microorganisms by an electrical charge |